Press release
Exanthema Market on Track for Transformative Growth by 2032, Forecasts DelveInsight
DelveInsight's "Exanthema - Market Insight, Epidemiology, And Market Forecast - 2032 [https://www.delveinsight.com/report-store/exanthema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr] report offers an in-depth understanding of the Exanthema, historical and forecasted epidemiology as well as the Exanthema market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Some of the key facts of the Exanthema Market Report:
- According to DelveInsight, the market for Exanthema in the 7MM is expected to witness notable growth during the study period from 2019 to 2032.
- As of February 2025, there were 164 reported measles cases in the U.S., with 93% of cases associated with outbreaks.
- In 2025, three outbreaks (defined as three or more related cases) have been reported, accounting for 93% of the 222 cases (207 cases). In contrast, 16 outbreaks were reported in 2024, representing 69% of the 285 cases (198 cases).
- For every 1,000 reported measles cases, about 1 case of encephalitis (brain inflammation) and 1 to 3 deaths occur.
- Between 1970 and 2005, infants aged
- In Sept 2024, Azitra, Inc. announced that the FDA granted Fast Track Designation for ATR-04, a topical treatment aimed at addressing moderate to severe skin rashes associated with Epidermal Growth Factor Receptor inhibitors (EGFRi). These rashes, often presenting as exanthema, significantly impact the quality of life for cancer patients undergoing EGFRi therapy. The Fast Track status underscores the urgent need for effective treatments in this area.
- In February 2023, GC Biopharma announced that its chickenpox vaccine, Barycela, received WHO pre-qualification, making it the fourth such vaccine worldwide to gain approval, following Merck's Varivax in 2018. This certification positions GC Biopharma to regain the global lead in chickenpox vaccine production.
- In June 2022, the FDA approved Priorix (measles, mumps, and rubella vaccine, live) for active immunization in individuals 12 months and older.
- Emerging drugs for the treatment of Exanthema include GSK4406371, TNM005, and others.
- Leading companies in the Chronic Pruritus market include GC Biopharma Corp, GlaxoSmithKline, Zhuhai Trinomab Pharmaceutical Co., Ltd., Sinovac (Dalian) Vaccine Technology Co., Ltd., and others.
To Know in detail about the Exanthema market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Exanthema Market Forecast [https://www.delveinsight.com/report-store/exanthema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Exanthema Overview
Exanthema refers to a widespread skin rash that often appears as a symptom of an underlying condition, such as viral or bacterial infections, drug reactions, or autoimmune disorders. The rash may be accompanied by fever, fatigue, or other systemic symptoms, depending on the cause. Common triggers include measles, rubella, roseola, and drug-induced hypersensitivity reactions. Diagnosis involves clinical evaluation, patient history, and, in some cases, laboratory testing to identify the underlying cause. Management varies based on etiology, ranging from symptomatic relief with antihistamines and corticosteroids to antiviral or antibiotic treatments.
Get a Free sample for the Exanthema Market Report: https://www.delveinsight.com/report-store/exanthema-market [https://www.delveinsight.com/report-store/exanthema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Exanthema Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Download the report to understand which factors are driving Exanthema epidemiology trends @ Exanthema Epidemiology Forecast [https://www.delveinsight.com/report-store/exanthema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Exanthema Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Exanthema market or expected to be launched during the study period. The analysis covers the Exanthema market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Exanthema Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Exanthema Market Strengths
- Improved diagnostic tools and treatment options, including biologics, enhance disease management.
- Increased knowledge among healthcare providers and patients leads to quicker diagnosis and treatment.
Exanthema Market Weaknesses
- Similar symptoms across different conditions can lead to challenges in accurate diagnosis.
- Many cases rely on symptomatic treatment rather than curative options, slowing market expansion.
Scope of the Exanthema Market Report
- Study Period: 2019-2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Exanthema Therapies: GSK4406371, TNM005, and others.
- Key Exanthema Companies: GC Biopharma Corp, GlaxoSmithKline, Zhuhai Trinomab Pharmaceutical Co., Ltd., Sinovac (Dalian) Vaccine Technology Co., Ltd., and others.
- Exanthema Therapeutic Assessment: Exanthema currently marketed and Exanthema emerging therapies
- Exanthema Market Dynamics: Exanthema market drivers and Exanthema market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
- Exanthema Unmet Needs, KOL's views, Analyst's views, Exanthema Market Access and Reimbursement
To learn more about the key players and advancements in the Exanthema Treatment Landscape, visit the Exanthema Market Analysis Report [https://www.delveinsight.com/report-store/exanthema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]
Table of Contents
1. Exanthema Market Report Introduction
2. Executive Summary for Exanthema
3. SWOT analysis of Exanthema
4. Exanthema Patient Share (%) Overview at a Glance
5. Exanthema Market Overview at a Glance
6. Exanthema Disease Background and Overview
7. Exanthema Epidemiology and Patient Population
8. Country-Specific Patient Population of Exanthema
9. Exanthema Current Treatment and Medical Practices
10. Exanthema Unmet Needs
11. Exanthema Emerging Therapies
12. Exanthema Market Outlook
13. Country-Wise Exanthema Market Analysis (2019-2032)
14. Exanthema Market Access and Reimbursement of Therapies
15. Exanthema Market Drivers
16. Exanthema Market Barriers
17. Exanthema Appendix
18. Exanthema Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=exanthema-market-on-track-for-transformative-growth-by-2032-forecasts-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exanthema Market on Track for Transformative Growth by 2032, Forecasts DelveInsight here
News-ID: 3910126 • Views: …
More Releases from ABNewswire
Roman Spiridonov and Petroruss: Pioneering Opportunities in Global Energy Trade
Petroruss, a Dubai-based independent trading house specializing in Russian energy resources and commodities, today announced its continued expansion as a leading force in global petroleum trading. Under the leadership of Managing Partner Roman Spiridonov, the company has solidified its role as a trusted partner in building efficient, reliable, and transparent supply chains.
Petroruss has distinguished itself in the energy sector by delivering seamless, economically viable commodity flows between producers and end-consumers.…
OptumMD Recognized as a Top-Rated Membership Based Functional Medicine Clinic in …
Recognition highlights OptumMD's systems-based, concierge approach to uncovering root causes and delivering personalized care.
Atlanta, GA - September 18, 2025 - OptumMD [https://optummd.com/], a membership-based concierge and functional medicine clinic serving Buckhead and Atlanta, announced it has been recognized as a top-rated functional medicine clinic in the area. The distinction underscores OptumMD's commitment to longer, more comprehensive visits, advanced diagnostic testing, and individualized care plans that aim to treat underlying causes…
Go Agencies Expands Done-For-You Business Opportunities with Flexible Ownership …
By pairing affordability with urgency, Go Agencies ensures that entrepreneurship feels not only possible but also essential. Each business is delivered fully branded and ready to operate from day one, with vendor relationships and client-ready systems included. The credibility of professionally structured agencies and the scarcity of limited availability make ownership both a smart investment and a time-sensitive decision.
Go Agencies is combining urgency with credibility to deliver one of the…
Risk Management: Gregory Blotnick on Drawdown Avoidance
Gregory Blotnick explains why drawdowns are damaging to the financial capital of a trader, but the true cost is measured in mental capital.
Image: https://www.abnewswire.com/upload/2025/09/44a32876f79b2f709bbade950cc28c07.jpg
In equity trading, risk management is often discussed in terms of numbers, volatility, and portfolio theory, but too often, the psychological side of risk is overlooked. Professional traders know that the hardest losses to recover from aren't always financial. They're mental. Protecting what Gregory Blotnick calls "mental…
More Releases for Exanthema
Exanthema Market New Product Development & Latest Trends
Introduction
Exanthema refers to widespread rashes or eruptions on the skin, often caused by viral infections, drug reactions, or bacterial diseases. It is commonly observed in conditions such as measles, rubella, roseola, and certain drug-induced reactions. While many cases resolve with supportive care, severe instances require medical intervention, especially among pediatric and immunocompromised patients.
With rising incidences of viral and bacterial infections, increasing global drug consumption, and stronger surveillance systems for dermatological…
Surge In Viral Infections Driving Growth Of The Market Due To Increasing Disease …
The Exanthema Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Exanthema Market?
There has been consistent growth in the exanthema market over the recent years. The market projection shows an increase from $2.18 billion in 2024 to $2.28 billion…
Exanthema Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Exanthema market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Exanthema Market, historical and forecasted epidemiology as well as the Exanthema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Exanthema market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Exanthema market size from 2019 to…
Exanthema Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Exanthema Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Exanthema, historical and forecasted epidemiology as well as the Exanthema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Exanthema market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Exanthema market size from 2019 to 2032, segmented…
Global Research on Exanthema Market: 2022, Growing Development Status, Segment O …
The "Exanthema Market" Research Report gives a far-reaching outline of the worldwide market size and share. It gives the information historically and forecasts data which incorporates information on the financial information of the worldwide market. The Exanthema market is carefully analyzed in the report with an emphasis on market dynamics, including key issues and challenges, drivers, trends, and opportunities. The report includes an in-depth analysis of significant market players to…
Exanthema Market 2021| Industry Size, Share, Demand, Manufacturers and Forecast …
Exanthema Market research report is constructed with the professional and in-depth study. This high quality report estimates current state of the market, market size and market share, revenue generated from the product sale, and necessary changes required in the future products. Accomplishing valuable market insights with the new skills, latest tools and innovative programs via this market document is sure to help the businesses achieve desired goals. A worldwide …
